Maesen B L, Snijder R J, Stricker B H
St. Antonius Ziekenhuis, afd. Longziekten, Nieuwegein.
Ned Tijdschr Geneeskd. 1994 Dec 10;138(50):2500-2.
Pulmonary hypertension was diagnosed in a 41-year-old woman after 16 months' use of fenfluramine as a treatment for obesity. Despite discontinuation, pulmonary pressure remained elevated. Drug-induced pulmonary hypertension is rare but has been reported relatively often after use of the sympathicomimetic agent aminorexfumarate, but also, although more rarely, of fenfluramine.
一名41岁女性在使用芬氟拉明治疗肥胖16个月后被诊断为肺动脉高压。尽管停药，但肺动脉压力仍持续升高。药物性肺动脉高压很罕见，但在使用拟交感神经药氨基雷司后相对经常有报道，使用芬氟拉明后也有报道，不过更为少见。
